Addressing a Public Health Concern presentation will share Merck's experience with development of a vaccine with speed to address the Ebola epidemic in 2014 and subsequent outbreaks. We will share what processes we used to develop a vaccine with speed.
Learn how Merck developed a vaccine rapidly to address an epidemic.
Learn about vaccine development and novel approaches to gain speed.
Learn how these methods could be applied to future epidemics and pandemics such as COVID19